NCT02920060View on ClinicalTrials.gov

Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Grand Mal Status Epilepticus
Interventions
DRUG

Intravenous levetiracetam

intravenous levetiracetam(30mg/kg bolus followed by 20mg/kg/dose IV 12 hourly).

DRUG

Sodium valproate

intravenous sodium valproate(20mg/kg bolus followed by 10 mg/kg/dose IV 8hrly)

All Listed Sponsors
collaborator

Institute of Medical Sciences of the Banaras Hindu University, India

OTHER

lead

Banaras Hindu University

OTHER

NCT02920060 - Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus | Biotech Hunter | Biotech Hunter